201
|
Johani K, Hu H, Santos L, Schiller S, Deva A, Whiteley G, Almatroudi A, Vickery K. Determination of bacterial species present in biofilm contaminating the channels of clinical endoscopes. Infect Dis Health 2018. [DOI: 10.1016/j.idh.2018.06.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
202
|
Li ZZ, Zhong WL, Hu H, Chen XF, Zhang W, Huang HY, Yu B, Dou X. Aryl hydrocarbon receptor polymorphisms are associated with dry skin phenotypes in Chinese patients with atopic dermatitis. Clin Exp Dermatol 2018; 44:613-619. [PMID: 30499126 DOI: 10.1111/ced.13841] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/20/2018] [Indexed: 01/23/2023]
Abstract
BACKGROUND Epidermal barrier dysfunction is the initial event in the development of atopic dermatitis (AD). Recent studies have identified a crucial role for the aryl hydrocarbon receptor (AHR) in controlling the gene expression of filaggrin and other skin barrier proteins, suggesting an underlying association between AHR and AD pathogenesis. AIM To investigate the role of AHR gene polymorphisms in the susceptibility to AD and in AD-associated phenotypes. METHODS We enrolled 487 patients with AD, 210 patients with psoriasis and 226 healthy controls (HCs) from the Han Chinese population, and genotyped two AHR single-nucleotide polymorphisms (rs10249788 and rs2066853) by PCR and subsequent DNA sequencing. RESULTS The AHR rs10249788 and rs2066853 polymorphisms were found in both sets of patients (AD and psoriasis) and in HCs, but no significant differences were detected in genotype or allele frequencies between the three groups. However, patients with AD with the rs10249788 (CT/TT) or rs2066853 (AG + AA) genotype were more likely to have severe dry skin scores. In the stratification analysis, the AHR rs2066853 (AG + AA) and rs10249788 (CT + TT) genotypes could predict a higher risk of severe dry skin phenotypes in the male, early-onset and allergic rhinitis subgroups. Furthermore, the combined rs10249788 (CT + TT) and rs2066853 (AG + AA) genotypes led to a higher risk for severe dry skin in patients with AD. CONCLUSION AHR polymorphisms are not associated with the risk of AD; however, they may predict a dry skin phenotype in patients with AD.
Collapse
Affiliation(s)
- Z Z Li
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.,Shenzhen Key Laboratory for Translational Medicine of Dermatology, Shenzhen-Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China
| | - W L Zhong
- Department of Dermatology, Peking University First Hospital, Beijing, China
| | - H Hu
- Shenzhen Key Laboratory for Translational Medicine of Dermatology, Shenzhen-Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China
| | - X F Chen
- Shenzhen Key Laboratory for Translational Medicine of Dermatology, Shenzhen-Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China
| | - W Zhang
- Shenzhen Key Laboratory for Translational Medicine of Dermatology, Shenzhen-Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, China
| | - H Y Huang
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - B Yu
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - X Dou
- Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| |
Collapse
|
203
|
Pitek AS, Hu H, Shukla S, Steinmetz NF. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles. ACS Appl Mater Interfaces 2018; 10:39468-39477. [PMID: 30403330 PMCID: PMC6485250 DOI: 10.1021/acsami.8b12499] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Nanotechnology holds great promise in cancer drug delivery, and of particular interest are theranostic approaches in which drug delivery and imaging are integrated. In this work, we studied and developed the plant virus tobacco mosaic virus (TMV) as a platform nanotechnology for drug delivery and imaging. Specifically, a serum albumin (SA)-coated TMV formulation was produced. The SA coating fulfils two functions: SA provides a stealth coating for enhanced biocompatibility; it also acts as a targeting ligand enabling efficient tumor accumulation of SA-TMV versus TMV in mouse models of breast and prostate cancer. We demonstrate drug delivery of the chemotherapy doxorubicin (DOX); TMV-delivered DOX outperformed free DOX, resulting in significant delayed tumor growth and increased survival. Furthermore, we demonstrated the ability of SA-coated TMV loaded with chelated Gd(DOTA) for magnetic resonance imaging detection of tumors. In the future, we envision the application of such probes as theranostic, where first imaging is performed to assess whether the nanoparticles are effective at targeting a particular patient tumor. If targeting is confirmed, the therapeutic would be added and treatment can begin. The combination of imaging and therapy would allow to monitor disease progression and therefore inform about the effectiveness of the drug delivery approach.
Collapse
Affiliation(s)
- A. S. Pitek
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States
| | - H. Hu
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States
- Department of NanoEngineering, Moores Cancer Center, University of California, San Diego, San Diego, California 92093, United States
| | - S. Shukla
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States
- Department of NanoEngineering, Moores Cancer Center, University of California, San Diego, San Diego, California 92093, United States
| | - N. F. Steinmetz
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States
- Department of NanoEngineering, Moores Cancer Center, University of California, San Diego, San Diego, California 92093, United States
| |
Collapse
|
204
|
Lopes LKO, Costa DM, Tipple AFV, Watanabe E, Castillo RB, Hu H, Deva AK, Vickery K. Complex design of surgical instruments as barrier for cleaning effectiveness, favouring biofilm formation. J Hosp Infect 2018; 103:e53-e60. [PMID: 30423413 DOI: 10.1016/j.jhin.2018.11.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2018] [Accepted: 11/02/2018] [Indexed: 01/26/2023]
Abstract
BACKGROUND Inadequately reprocessed reusable surgical instruments (RSIs) may harbour infectious agents which may then be transferred to a suitable site for replication. AIM To determine the cumulative effect of 20 cycles of contamination, cleaning (manual or manual followed by automated) and steam sterilization on high-complex-design RSIs used for orthopaedic surgery. METHODS New flexible medullary reamers and depth gauges were contaminated by soaking in tryptone soya broth, containing 5% sheep blood and 109 cfu/mL of Staphylococcus aureus (ATCC 25923), for 5 min. To mimic a worse-case scenario, RSIs were dried 7 h and subjected to either (a) rinsing in distilled water, (b) manual cleaning or (c) manual plus automated cleaning (reference standard), and steam sterilization. The contamination, cleaning, and sterilization cycle was repeated 20 times. Adenosine triphosphate (ATP) was measured after cleaning procedures; microbial load and residual protein were measured following the 10th and 20th reprocessing, in triplicate. Scanning electron microscopy (SEM) was used to confirm soil and biofilm presence on the RSIs after the 20th reprocessing. FINDINGS Manual and manual plus automated cleaning significantly reduced the amount of ATP and protein residues for all RSIs. Viable bacteria were not detected following sterilization. However, SEM detected soil after automated cleaning, and soil, including biofilms, after manual cleaning. CONCLUSION Soil and/or biofilms were evident on complex-design RSIs following 20 cycles of contamination and reprocessing, even using the reference standard method of cleaning. Although the depth gauges could be disassembled, biological residues and biofilm accumulated in its lumen. The current design of these RSIs prevents removal of all biological soil and this may have an adverse effect on patient outcome.
Collapse
Affiliation(s)
- L K O Lopes
- Faculty of Nursing, Federal University of Goiás, Goiânia, Brazil; Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - D M Costa
- Faculty of Nursing, Federal University of Goiás, Goiânia, Brazil; Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - A F V Tipple
- Faculty of Nursing, Federal University of Goiás, Goiânia, Brazil
| | - E Watanabe
- School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
| | - R B Castillo
- Macquarie University Hospital, Macquarie University, Sydney, Australia
| | - H Hu
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - A K Deva
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - K Vickery
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
| |
Collapse
|
205
|
Zhang J, Hu H, Wu Z, Cai Y, Ling J, Xiao J, Deng YH. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A propensity score analysis from two prospective trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy431.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
206
|
Abstract
Kawasaki disease (KD) is an immune-mediated vasculitis with symptoms that mimic febrile illness; the immune origin has been suggested but never proved. First, cell chip technology was used to screen immune targets cells. With the indirect immunofluorescence assay we found that the HeLa cell chip could be recognized by KD patient serum samples. The target cell proteome was extracted as antigens, and antigen recognition reaction was performed using the patients' serum as antibodies and the detected target protein was detected and identified as phosphoglycerate kinase 1 (PGK1). Then PGK1 was produced and tested with enzyme-linked immunosorbent assay (ELISA), Western blotting, immunoprecipitation and competitive inhibition immunofluorescence assay. Immunoglobulin (Ig)G against PGK1 was detected in 46% (23 of 50) sera of KD patients, 13% (five of 38) sera in febrile non-KD patients (FC) and 2·6% (one of 38) sera in healthy donors. As an immune target, PGK1 not only helps understanding of the pathogenesis, it also has potential value in facilitating the laboratory diagnosis of KD.
Collapse
Affiliation(s)
- J Cui
- 112 Laboratory, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China
| | - Y Zhou
- 112 Laboratory, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China
| | - H Hu
- Department of Pediatrics, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, China
| | - L Zhao
- 112 Laboratory, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China
| | - Z Du
- Department of Pediatrics, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, China
| | - H Du
- 112 Laboratory, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, China
| |
Collapse
|
207
|
Zhang J, Deng Y, Wu Z, Hu H, Cai Y, Ling J. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A propensity score analysis from two prospective trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy281.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
208
|
Kato T, Jin C, Ujiie H, Fujino K, Lee D, Wada H, Hu H, Wu L, Weersink R, Chen J, Kanno H, Hatanaka Y, Hatanaka K, Matsuno Y, De Perrot M, Wilson B, Zheng G, Yasufuku K. MA12.09 Preclinical Investigations of Folate Receptor Targeted Nanoparticles for Photodynamic Therapy of Malignant Pleural Mesothelioma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
209
|
Dong G, Hu H, Wang L, Zhang Y, Bi Y. Remarkable enhancement on photoelectrochemical water splitting derived from well-crystallized Bi2WO6 and Co(OH)x with tunable oxidation state. J Catal 2018. [DOI: 10.1016/j.jcat.2018.08.010] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
210
|
Ge W, Cai W, Hu H. A novel 4-gene prognostic signature for hypermutated colorectal cancer (CRC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy318.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
211
|
Zhou JH, Wang D, Wang HR, Hou XL, Yu WD, Xu KX, Hu H. [Cytotoxic effects of γδT cells on bladder cancer cells and expression of MICA/B in bladder cancer]. Beijing Da Xue Xue Bao Yi Xue Ban 2018; 50:595-601. [PMID: 30122755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 09/28/2022]
Abstract
OBJECTIVE To explore the role of γδT cells against bladder cancer and to detect the expression of stress proteins MICA/B recognized by γδT cells in bladder cancer. METHODS γδT cells from peripheral blood drawn from 6 bladder cancer patients with pamidronate stimulating were expanded. Flow cytometry was used to detect the purity and expansion folds of γδT cells, and the expression of CD107a on γδT cells after PMA/ionomycin stimulated. The cytotoxicity assay was carried out to test the cytotoxicity of γδT cells against human bladder cancer cell lines. The expression of MICA/B on bladder cancer cell lines and in bladder cancer tissues were detected through flow cytometry and immunohistochemistry respectively. RESULTS γδT cells from peripheral blood drawn from 6 bladder cancer patients were successfully expanded. The purity was 75%-94% and the expansion folds were 109-371 times. After being stimulated by PMA/ionomycin, the proportion of CD107a+ γδT cells increased significantly, reaching 40%-82%. γδT cells from the 6 bladder cancer patients showed obvious cytotoxic effects on 3 human bladder cancer cell lines which was enhanced as the effector: the target ratio increased. MICA/B were detected both in 3 bladder cancer cell lines and in 26 bladder cancer tissues. The staining score of MICA/B in invasive bladder cancer was slightly higher than that in non-invasive bladder cancer, and in advanced bladder cancer was higher than that in low grade bladder cancer, but the statistical analysis showed that the staining score of MICA/B was no significant correlation between the tissue and the tumor stages and grades. CONCLUSION γδT cells from the peripheral blood of the bladder cancer patients could be successfully expanded in vitro, and showed significant anti-bladder cancer effect. MICA/B were detected both in bladder cancer cell lines and in bladder cancer tissues. The statistical analysis showed that there was no significant correlation between the staining scores of MICA/B in the tissue and the tumor stages and grades.
Collapse
Affiliation(s)
- J H Zhou
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing 100044, China
| | - D Wang
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing 100044, China
| | - H R Wang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - X L Hou
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing 100044, China
| | - W D Yu
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing 100044, China
| | - K X Xu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - H Hu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| |
Collapse
|
212
|
Wang HR, Zhang WY, Liu XH, Hu H, Zhang XP, Xu KX. [Clinical application of partial cystectomy with augmentation cystoplasty for invasive bladder cancer in elderly patients]. Beijing Da Xue Xue Bao Yi Xue Ban 2018; 50:626-629. [PMID: 30122761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
OBJECTIVE To evaluate the clinical effect and safety of biological patch applied in elderly patients with invasive bladder cancer who underwent massive partial cystectomy with augmentation cystoplasty. METHODS The clinical data of 2 patients with invasive bladder cancer from October 2016 to March 2017, who underwent the massive partial cystectomy with augmentation cystoplasty were retrospectively reviewed. Case one was an 87-year-old man, with tumor located on the bladder anterior wall, ranging from 5.5 cm×2.5 cm, and the grade of American Society of Anesthesiologists (ASA) being III. Case two was a 77-year-old female, whose lesion was located on the right anterior wall, ranging from 5.2 cm×4.0 cm, and the grade of ASA being II. Both of the patients received a massive partial cystectomy with augmentation cystoplasty. The operative time, estimated blood loss, perioperative and postoperative data and follow-up data, including cystoscopy and urodynamics were recorded and compared. When the P value was less than 0.05, it was statistically significant. RESULTS All the operations were successfully performed. The average operative time was (155.0+35.4) min, mean estimated intraoperative blood loss was 20 to 100 mL, and the mean postoperatively hospital stay was eight days. During the 10 to 14 months' follow-up periods, no local recurrence or distant metastasis occurred. Urodynamic data: the maximum urinary flow rate was 16.5 mL/s, and the maximum bladder capacity was 303 mL. The two patients urinated 3-4 times in the day time, 0 to 3 times in the night, 200-300 mL each time, on average. The American Urological Association symptom score was 3 to 5. Partial cystectomy, applied to aged patients with multiple complications and high risk of surgical anesthesia, was able to reduce surgery related complications. For patients with tumor of small size, the normal bladder wall would be enough to recover functional capacity for urine storing after partial cystectomy. For patients with large lesions range and small normal bladder tissues, augmentation cystoplasty would help recover bladder capacity on the condition of negative margin. CONCLUSION Massive partial cystectomy with augmentation cystoplasty is safe and effective. It could decrease perioperative morbidity and keep the quality-of-life benefits of bladder preservation, which is worthy of further application for some selected invasive bladder cancer in elderly patients.
Collapse
Affiliation(s)
- H R Wang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - W Y Zhang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - X H Liu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - H Hu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - X P Zhang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - K X Xu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| |
Collapse
|
213
|
Hu H, Fang Y, Wei B, Cui K, Cen Z, Luo C, He P. P3867Transhepatic route for cardiac implantable electronic devices(CIED) implantation in patients with inaccessible superior vena cava route: 5 years experiences. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Affiliation(s)
- H Hu
- West China Hospital Sichuan University, cardiovascular department, Chengdu, China People's Republic of
| | - Y Fang
- West China Hospital Sichuan University, cardiovascular department, Chengdu, China People's Republic of
| | - B Wei
- West China Hospital Sichuan University, Gastroenterology department, Chengdu, China People's Republic of
| | - K Cui
- West China Hospital Sichuan University, cardiovascular department, Chengdu, China People's Republic of
| | - Z Cen
- West China Hospital Sichuan University, cardiovascular department, Chengdu, China People's Republic of
| | - C Luo
- Mianyang Central Hospital, cardiovascular department, Mianyang, China People's Republic of
| | - P He
- West China Hospital Sichuan University, anesthesiology department, Chengdu, China People's Republic of
| | | |
Collapse
|
214
|
Wang RX, Tong XL, Gai TT, Li CL, Qiao L, Hu H, Han MJ, Xiang ZH, Lu C, Dai FY. A serine protease homologue Bombyx mori scarface induces a short and fat body shape in silkworm. Insect Mol Biol 2018; 27:319-332. [PMID: 29441628 DOI: 10.1111/imb.12373] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Body shape is one of the most prominent and basic characteristics of any organism. In insects, abundant variations in body shape can be observed both within and amongst species. However, the molecular mechanism underlying body shape fine-tuning is very complex and has been largely unknown until now. In the silkworm Bombyx mori, the tubby (tub) mutant has an abnormal short fat body shape and the abdomen of tub larvae expands to form a fusiform body shape. Morphological investigation revealed that the body length was shorter and the body width was wider than that of the Dazao strain. Thus, this mutant is a good model for studying the molecular mechanisms of body shape fine-tuning. Using positional cloning, we identified a gene encoding the serine protease homologue, B. mori scarface (Bmscarface), which is associated with the tub phenotype. Sequence analysis revealed a specific 312-bp deletion from an exon of Bmscarface in the tub strain. In addition, recombination was not observed between the tub and Bmscarface loci. Moreover, RNA interference of Bmscarface resulted in the tub-like phenotype. These results indicate that Bmscarface is responsible for the tub mutant phenotype. This is the first study to report that mutation of a serine protease homologue can induce an abnormal body shape in insects.
Collapse
Affiliation(s)
- R-X Wang
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - X-L Tong
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - T-T Gai
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - C-L Li
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - L Qiao
- Institute of Entomology and Molecular Biology, College of Life Sciences, Chongqing Normal University, Chongqing, China
| | - H Hu
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - M-J Han
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - Z-H Xiang
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - C Lu
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| | - F-Y Dai
- State Key Laboratory of Silkworm Genome Biology, Key Laboratory of Sericultural Biology and Genetic Breeding, Ministry of Agriculture, Southwest University, Chongqing, China
| |
Collapse
|
215
|
Johani K, Fritz BG, Bjarnsholt T, Lipsky BA, Jensen SO, Yang M, Dean A, Hu H, Vickery K, Malone M. Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches. Clin Microbiol Infect 2018; 25:332-339. [PMID: 29787888 DOI: 10.1016/j.cmi.2018.04.036] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 04/30/2018] [Accepted: 04/30/2018] [Indexed: 01/13/2023]
Abstract
OBJECTIVES Rigorous visual evidence on whether or not biofilms are involved in diabetic foot osteomyelitis (DFO) is lacking. We employed a suite of molecular and microscopic approaches to investigate the microbiome, and phenotypic state of microorganisms involved in DFO. METHODS In 20 consecutive subjects with suspected DFO, we collected intraoperative bone specimens. To explore the microbial diversity present in infected bone we performed next generation DNA sequencing. We used scanning electron microscopy (SEM) and peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) with confocal microscopy to visualize and confirm the presence of biofilms. RESULTS In 19 of 20 (95%) studied patients presenting with DFO, it was associated with an infected diabetic foot ulcer. By DNA sequencing of infected bone, Corynebacterium sp. was the most commonly identified microorganism, followed by Finegoldia sp., Staphylococcus sp., Streptococcus sp., Porphyromonas sp., and Anaerococcus sp. Six of 20 bone samples (30%) contained only one or two pathogens, while the remaining 14 (70%) had polymicrobial communities. Using a combination of SEM and PNA-FISH, we identified microbial aggregates in biofilms in 16 (80%) bone specimens and found that they were typically coccoid or rod-shaped aggregates. CONCLUSIONS The presence of biofilms in DFO may explain why non-surgical treatment of DFO, relying on systemic antibiotic therapy, may not resolve some chronic infections caused by biofilm-producing strains.
Collapse
Affiliation(s)
- K Johani
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - B G Fritz
- University of Copenhagen, Faculty of Health and Medical Sciences, Department of Immunology and Microbiology, Costerton Biofilm Center, Denmark
| | - T Bjarnsholt
- University of Copenhagen, Faculty of Health and Medical Sciences, Department of Immunology and Microbiology, Costerton Biofilm Center, Denmark; Department of Clinical Microbiology, Rigshospitalet, Denmark
| | - B A Lipsky
- Oxford Microbiology and Infectious Diseases, University of Oxford, Oxford, UK
| | - S O Jensen
- Infectious Diseases and Microbiology, School of Medicine, Western Sydney University, Australia
| | - M Yang
- Liverpool Hospital, South Western Sydney LHD, Sydney, Australia
| | - A Dean
- Liverpool Hospital, South Western Sydney LHD, Sydney, Australia
| | - H Hu
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - K Vickery
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - M Malone
- Infectious Diseases and Microbiology, School of Medicine, Western Sydney University, Australia; Liverpool Hospital, South Western Sydney LHD, Sydney, Australia; Liverpool Diabetes Collaborative Research Unit, Ingham Institute of Applied Medical Research, Sydney, Australia.
| |
Collapse
|
216
|
Han Z, Hu H, Yin M, Li X, Li J, Liu L, Liu B. miR-145 is critical for modulation of vascular smooth muscle cell proliferation in human carotid artery stenosis. J BIOL REG HOMEOS AG 2018; 32:506-516. [PMID: 29921375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
miR-145 is highly expressed in vascular cells, where it regulates phenotypic switching and vascular homeostasis, but its role in carotid artery stenosis (CAS) is controversial. In the present study, the expression of miR-145 was assessed by real time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) in human samples (both plasma and/or endarterectomy samples) from patients with symptomatic CAS and in controls without CAS. The mouse carotid artery ligation (CAL) model was used to determine the role of miR-145 on vascular smooth muscle cells in vivo (VSMCs) by using a mimic of or an inhibitor of miR-145. We found that miR-145 expression was significantly reduced in the plasma and plaque from patients with CAS (p less than 0.01). The expression of miR-145 in the mouse CAL model, as assessed by qRT-PCR, was significantly reduced compared to the carotid arteries of the control group (p less than 0.01). In vitro, enhancement or inhibition of miR-145 in VSMCs demonstrated that miR-145 significantly inhibited proliferation of VSMCs (p less than 0.05); in vivo, enhancement of miR-145 significantly inhibited neointimal formation in the CAL model (p less than 0.01). These results demonstrate that the expression of miR-145 is reduced in human CAS, miR-145 plays a critical role in CAS by modulation of VSMC proliferation, suggesting that MiR-145 may present a potential therapeutic option for treating CAS.
Collapse
Affiliation(s)
- Z Han
- Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
| | - H Hu
- Department of Vascular and Thyroid Surgery, the First Hospital of China Medical University, Shenyang, China
| | - M Yin
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
- Pathology and the Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, USA
| | - X Li
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
| | - J Li
- Department of Endodontics, the First Affiliated Hospital of Harbin Medical University, Harbin, China
| | - L Liu
- Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
| | - B Liu
- Department of General Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China
| |
Collapse
|
217
|
Malone M, Johani K, Jensen SO, Gosbell IB, Dickson HG, McLennan S, Hu H, Vickery K. Effect of cadexomer iodine on the microbial load and diversity of chronic non-healing diabetic foot ulcers complicated by biofilm in vivo. J Antimicrob Chemother 2018; 72:2093-2101. [PMID: 28402558 PMCID: PMC5890712 DOI: 10.1093/jac/dkx099] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2016] [Accepted: 03/03/2017] [Indexed: 12/27/2022] Open
Abstract
Objectives: The performance of cadexomer iodine was determined against microbial populations from chronic non-healing diabetic foot ulcers (DFUs) complicated by biofilm in vivo, using molecular, microscopy and zymography methods. Methods: Chronic non-healing DFUs due to suspected biofilm involvement were eligible for enrolment. DNA sequencing and real-time quantitative PCR was used to determine the microbial load and diversity of tissue punch biopsies obtained pre- and post-treatment. Scanning electron microscopy and/or fluorescence in situ hybridization confirmed the presence or absence of biofilm. Zymography was used to determine levels of wound proteases. Results: Seventeen participants were recruited over a 6 month period. Scanning electron microscopy and or fluorescence in situ hybridization confirmed the presence of biofilm in all samples. Eleven participants exhibited log10 reductions in microbial load after treatment (range 1–2 log10) in comparison with six patients who experienced <1 log10 reduction (P = 0.04). Samples were tested for levels of wound proteases pre- and post-treatment. Reductions in the microbial load correlated to reductions in wound proteases pre- and post-treatment (P = 0.03). Conclusions: To the best of our knowledge, this study represents the first in vivo evidence, employing a range of molecular and microscopy techniques, of the ability of cadexomer iodine to reduce the microbial load of chronic non-healing DFUs complicated by biofilm. Further analyses correlating log reductions to optimal duration of therapy and improvements in clinical parameters of wound healing in a larger cohort are required.
Collapse
Affiliation(s)
| | - K Johani
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - S O Jensen
- Molecular Medicine Research Group, Microbiology & Infectious Diseases, School of Medicine, Western Sydney University, Sydney, Australia.,Antimicrobial Resistance and Mobile Elements Group, Ingham Institute of Applied Medical Research, Sydney, Australia
| | - I B Gosbell
- Molecular Medicine Research Group, Microbiology & Infectious Diseases, School of Medicine, Western Sydney University, Sydney, Australia.,Antimicrobial Resistance and Mobile Elements Group, Ingham Institute of Applied Medical Research, Sydney, Australia
| | - H G Dickson
- Liverpool Diabetes Collaborative Research Unit, Ingham Institute of Applied Medical Research, Sydney, Australia.,Ambulatory Care Department (PIXI), Liverpool Hospital, South West Sydney LHD, Sydney, Australia
| | - S McLennan
- The University of Sydney, Charles Perkins Centre, NSW, Australia
| | - H Hu
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| | - K Vickery
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
| |
Collapse
|
218
|
Wu X, Hu H, Ying S, Guo X. 3:18 PM Abstract No. 401 Efficacy and safety of CalliSpheres ® drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
219
|
Yu C, Wang J, Wang F, Han X, Hu H, Yuan J, Miao X, Yao P, Wei S, Wang Y, Liang Y, Chen W, Zhang X, Guo H, Yang H, Tang Y, Zheng D, Wu T, He M. Inverse association between plasma homocysteine concentrations and type 2 diabetes mellitus among a middle-aged and elderly Chinese population. Nutr Metab Cardiovasc Dis 2018; 28:278-284. [PMID: 29337020 DOI: 10.1016/j.numecd.2017.11.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2017] [Revised: 11/16/2017] [Accepted: 11/27/2017] [Indexed: 11/25/2022]
Abstract
BACKGROUND AND AIMS Plasma homocysteine concentrations have been reported to be associated with type 2 diabetes mellitus (T2DM) with controversial findings. The aim of the present study was to investigate the association between plasma homocysteine concentrations and T2DM. METHODS AND RESULTS A cross-sectional study including 19,085 eligible participants derived from the Dongfeng-Tongji cohort was conducted. Plasma homocysteine concentrations were measured by Abbott Architect i2000 Automatic analyzer and T2DM was defined according to American Diabetes Association criteria. Logistic regression model was used to explore the association between plasma homocysteine concentrations and T2DM. The prevalence of T2DM was 19.0% in the whole population (mean age 62.9 years), 21.8% in males, and 17.1% in females. In the multivariable logistic regression analyses, compared with those in the lowest quintile, the OR (95% CI) of T2DM was 1.05 (0.92-1.21), 0.99 (0.86-1.14), 0.90 (0.78-1.05), and 0.77 (0.66-0.90) for quintile 2 to quintile 5 of homocysteine concentrations after adjustment for potential confounders (P for trend < 0.0001). Homocysteine concentrations were associated with decreased T2DM prevalence risk (OR = 0.88 per SD increase of homocysteine concentration; 95% CI: 0.84-0.93). A significant interaction between homocysteine concentrations and drinking status on T2DM prevalence risk was observed (P for interaction = 0.03). The inverse association of plasma homocysteine concentrations with T2DM prevalence risk was observed in non-drinkers but not in current drinkers. CONCLUSION Plasma homocysteine concentrations were inversely correlated with T2DM among a middle-aged and elderly Chinese population.
Collapse
Affiliation(s)
- C Yu
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - J Wang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - F Wang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - X Han
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - H Hu
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - J Yuan
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - X Miao
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - P Yao
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - S Wei
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Wang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Liang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - W Chen
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - X Zhang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - H Guo
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - H Yang
- Dongfeng Central Hospital, Dongfeng Motor Corporation and Hubei University of Medicine, Shiyan, Hubei, China
| | - Y Tang
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - D Zheng
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - T Wu
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - M He
- Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
| |
Collapse
|
220
|
Wang F, Wang J, Li Y, Han X, Hu H, Yu C, Yuan J, Yao P, Miao X, Wei S, Wang Y, Chen W, Liang Y, Guo H, Zhang X, Yang H, Wu T, He M. Associations between daily cooking duration and the prevalence of diabetes and prediabetes in a middle-aged and elderly Chinese population: A cross-sectional study. Indoor Air 2018; 28:238-246. [PMID: 29028277 DOI: 10.1111/ina.12434] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2017] [Accepted: 10/06/2017] [Indexed: 06/07/2023]
Abstract
Experimental and epidemiological studies indicated that ambient air pollution was positively associated with diabetes. Few studies investigated the associations between household air pollution, for example, daily cooking duration and diabetes or prediabetes. We conducted a cross-sectional study to investigate the associations of daily cooking duration with the prevalence of diabetes and prediabetes among a middle-aged and elderly population. A total of 26 089 individuals (11 250 males and 14 839 females) derived from the Dongfeng-Tongji cohort study were included. Daily cooking duration was assessed by questionnaire. Diabetes and prediabetes were identified according to the criterion of American Diabetes Association. No significant association was observed between daily cooking duration and the prevalence risk of diabetes (odds ratio[OR] = 0.97, 95% confidence interval[CI]: [0.81-1.16], P for trend = .74); however, longer daily cooking duration was associated with higher prevalence risk of prediabetes (OR = 1.26, 95% CI: 1.07-1.47; P for trend = .003) and hyperglycemia (OR = 1.21, 95% CI: 1.05-1.41; P for trend = .005). Our study suggested that daily cooking duration was not associated with diabetes but with higher prevalence risk of prediabetes/hyperglycemia in a middle-aged and elderly Chinese population.
Collapse
Affiliation(s)
- F Wang
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Wang
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y Li
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - X Han
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - H Hu
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - C Yu
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - J Yuan
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - P Yao
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - X Miao
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - S Wei
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y Wang
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - W Chen
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Y Liang
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - H Guo
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - X Zhang
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - H Yang
- Dongfeng Central Hospital, Dongfeng Motor Corporation and Hubei University of Medicine, Shiyan, China
| | - T Wu
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - M He
- Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| |
Collapse
|
221
|
Cheng X, Zhang Y, Hu H, Shang M, Bi Y. High-efficiency SrTiO 3/TiO 2 hetero-photoanode for visible-light water splitting by charge transport design and optical absorption management. Nanoscale 2018; 10:3644-3649. [PMID: 29424380 DOI: 10.1039/c7nr09023d] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Herein, a two-pronged approach to obtain excellent visible-light performance of SrTiO3/TiO2 photoelectrodes for water oxidation is presented. More specifically, the combination of hetero-constructing SrTiO3 nanocubes and Cr3+/Ti3+ dual-doping has been demonstrated for achieving high efficiency of charge separation and extending photoresponse of TiO2 nanotube arrays from the UV to visible light region. As expected, this unique Cr-SrTiO3-x/Cr-TiO2-x photoanode exhibited remarkably improved PEC performance for water splitting (4.05 mA cm-2) under visible light irradiation, which is more than 100 times higher than that of pristine TiO2 nanotube arrays. Additionally, the photocurrent intensity as well as water splitting behavior remain constant even after long time irradiation, revealing its high PEC as well as structure stability. Thereby, the rational design of the interface charge transport and precise management of optical absorption endow the TiO2-based PEC system with excellent and stable visible-light performance for water splitting.
Collapse
Affiliation(s)
- Xiang Cheng
- State Key Laboratory for Oxo Synthesis & Selective Oxidation, National Engineering Research Center for Fine Petrochemical Intermediates, Lanzhou Institute of Chemical Physics, CAS, Lanzhou, Gansu 730000, China.
| | | | | | | | | |
Collapse
|
222
|
Praveen Kumar A, Kovatich AJ, Biancotto A, Cheung F, Davidson-Moncada JK, Kvecher L, Liu J, Ru Y, Kovatich AW, Deyarmin B, Fantacone-Campbell JL, Hooke JA, Raj Kumar PK, Rui H, Hu H, Shriver CD. Abstract P4-09-14: Analysis of breast cancer recurrence using gene set enrichment analysis. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-09-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Even after successful treatment of primary breast tumors, there is a continued risk of recurrence. The risk varies between subtypes and there are ongoing efforts that aim to improve prediction of such risks for individual patients. Detection of subclinical metastases might be achieved by biomarkers in blood. In this study, we profiled protein expression in blood plasma from patients with known clinical outcome (recurrence vs no recurrence) to identify prognostic markers of breast cancer recurrence.
Methods: The subjects and specimens were made available through the Clinical Breast Care Project using IRB-approved protocols. We analyzed blood plasma samples taken at the time of diagnosis from consented patients who subsequently relapsed (33 cases) as well as those with no disease recurrence (31 controls). Based on hormone receptor and lymph node status the samples were grouped as: ER-/HER2- (17 cases/15 controls), ER+/LN+ (10/10) and ER+/LN- (6/6). We used aptamer-based SOMAscan assay platform to study the expression of 1252 proteins. We analyzed the protein expression data by using their coding genes in order to apply the Gene Set Enrichment Analysis method (GSEA v.2, Broad Institute). Pathway databases of KEGG, REACTOME, BIOCARTA and C4 collection were used. Significant gene sets were called at 5% FDR, and overlaps and low coverage gene sets (Tags <70%) were removed. Statistical analysis and clustering were done using R.
Results: Unsupervised clustering showed some difference in signal in the ER+/LN- group. Even though there was a lack of significantly differentiated proteins between the cases and controls of this group, many significant gene sets were identified. After applying the cutoff filters and removing the overlaps, there were 5 gene sets enriched with the pathway collection, involved in B-cell receptor signaling, mRNA metabolism, tight junction and SCF-KIT signaling. Similarly, 9 gene sets from the MORF compendium were differentially expressed with the C4 collection and included neighborhood genes of NME2, ACTG1, EIF3S2, AP2M1, DAP3, UBE2I, NPM1, AATF and NPM1. In contrast, neither differentially expressed proteins nor gene sets were identified from the ER+/LN+ and ER-/HER2- groups. Since the sample size of the ER+/LN- group was small, we conducted a similar analysis by randomly choosing 6 case and control samples in the other two groups respectively. There were still no differentially expressed proteins or gene sets identified above the specified cutoff parameters.
Conclusion: Using plasma protein expression data we identified underlying gene sets differentially expressed between ER+/LN- patients who had cancer recurrence and no recurrence. Many genes in these sets were already known biomarkers (e.g. PTEN, AKT1, STAT3, SET etc.). These results can be used for understanding patterns of recurrence in different cancer subtypes. Further research is needed to estimate the clinical significance of these gene products.
The views expressed in this article are those of the author and do not reflect the official policy of the Department of Army/Navy/Air Force, the Department of Defense, or U.S. Government.
Citation Format: Praveen Kumar A, Kovatich AJ, Biancotto A, Cheung F, Davidson-Moncada JK, Kvecher L, Liu J, Ru Y, Kovatich AW, Deyarmin B, Fantacone-Campbell JL, Hooke JA, Raj Kumar PK, Rui H, Hu H, Shriver CD. Analysis of breast cancer recurrence using gene set enrichment analysis [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-09-14.
Collapse
Affiliation(s)
- A Praveen Kumar
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - AJ Kovatich
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - A Biancotto
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - F Cheung
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - JK Davidson-Moncada
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - L Kvecher
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - J Liu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - Y Ru
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - AW Kovatich
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - B Deyarmin
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - JL Fantacone-Campbell
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - JA Hooke
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - PK Raj Kumar
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - H Rui
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - H Hu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - CD Shriver
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; National Institutes of Health, Bethesda, MD; MacroGenics, Inc, Rockville, MD; MDR Global Systems, Windber, PA; Medical College of Wisconsin, Milwaukee, WI; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| |
Collapse
|
223
|
Raj-Kumar PK, Liu J, Kovatich AJ, Kvecher L, Shriver CD, Hu H. Abstract P2-06-04: Use of principal component analyses to select ER-balanced subset for gene centering in PAM50 subtyping. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p2-06-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: PAM (Prediction Analysis of Microarray) 50 is an established gene expression-based algorithm to classify breast tumors into basal-like, HER2-enriched, luminal A (LA), and luminal B (LB) subtypes. Clinical subtyping is mainly based on immunohistochemistry (IHC) assays of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her2) and Ki67 classifying tumors into triple-negative (ER-/PR-/Her2-), Her2+ (ER-/PR-/Her2+), LA (ER+/Her2-/Ki67-), LB1 (ER+/Her2-/Ki67+) and LB2 (ER+/Her2+). These two subtyping methods do not completely match even on comparable subtypes. Nevertheless, the ER-balanced subset for gene-centering in PAM50 subtyping was selected based on clinical status. Here we explored the possibility of using principal component analyses and iterative PAM50 call to refine the selection of an ER balance subset to improve consistency between these methods focusing on LB calls which is more aggressive than LA tumors.
Methods: Normalized gene expression data was obtained from TCGA research network for 712 primary tumors which had IHC status available for ER, PR and Her2. Since Ki67 status was not available LA and LB was discriminated for ER+ cases with Her2- and Her2+ respectively. In house RNA-Seq dataset had 118 primary tumors and were drawn from the Clinical Breast Care Project where breast cancer patients were consented using an IRB-approved protocol. Tumors were selected and processed by laser microdissection. RNA was extracted from tissues using the Illustra triplePrep kit (GE Healthcare). Paired-end mRNA sequencing was performed using the Illumina HiSeq platform. Sequenced reads were processed using PERL based pipeline utilizing PRINSEQ, GSNAP and HTSeq. Principal component analysis (PCA) was done using R. Wilcoxon rank sum test was used for statistical significance (p<0.05).
Results: In both datasets, the PCA map grouping of cases does not perfectly reflect the clinical subtypes. This motivated us to select ER balance subset based on the PC1 separation and IHC subtype. The resulting PAM50 subtypes on PCA map distinguished Basal and LA as two well separated components. Using all of Basal and equal number of LA cases for ER balance subset for PAM50 resulted in increased LB call and a better consistency with IHC LB calls. Among 712 cases in TCGA LB numbers increased from 142 in initial PAM50 call to 203 in ER balanced refined PAM50 call. We noticed that there was significantly higher (p-value = 4.414e-11) MKI67 expression for the 39 cases switch from LA to LB between PAM50 calls. Similar trend was observed in our in-house dataset where majority of the IHC-LB1 cases was called as LB in PAM50. The new method increased LB call from 22 to 27 which in-turn increased consistency between molecular and clinical subtypes from 73 to 79 out of the total of 118 cases.
Conclusion: We show that an iterative PAM50 call coupled with PCA for selection of ER balance set potentially enhanced the consistency of the LB calls with clinical subtyping and that the tumors switched from LA to LB have high MKI67 expression.
The views expressed in this article are those of the author and do not reflect the official policy of the Department of Army/Navy/Air Force, the Department of Defense, or U.S. Government.
Citation Format: Raj-Kumar P-K, Liu J, Kovatich AJ, Kvecher L, Shriver CD, Hu H. Use of principal component analyses to select ER-balanced subset for gene centering in PAM50 subtyping [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P2-06-04.
Collapse
Affiliation(s)
- P-K Raj-Kumar
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - J Liu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - AJ Kovatich
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - L Kvecher
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - CD Shriver
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - H Hu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| |
Collapse
|
224
|
Sethunath V, Hu H, De Angelis C, Veeraraghavan J, Qin L, Rimawi MF, Osborne KC, Schiff R. Abstract P4-03-04: Targeting the mevalonate pathway in HER2-positive breast cancer to overcome resistance to anti-HER2 therapy. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-03-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Despite the advent of HER2-targeted therapies for HER2+ breast cancer (BC), including the monoclonal antibody trastuzumab (T) either alone or in combinations, resistance still poses a major clinical challenge. Using our broad panel of HER2+ cell lines made resistant (R) to T alone (TR), and to lapatinib plus T (LTR), we observed that in resistant models where HER2 remains inhibited, especially the LTR derivative, the mevalonate (MVA) pathway is activated and provides an alternative proliferative signal, including the activation of mTOR, to drive resistance. While these resistant cell models were hypersensitive to the widely-used cholesterol-lowering statins, the role of other MVA pathway inhibitors such as zoledronic acid (ZA), which is in clinical use to treat bone metastasis, in overcoming resistance to HER2-targeted therapy has not been explored. Based on recent reports and our preliminary data using reverse phase protein array (RPPA) analysis, the YAP/TAZ transcription factor (TF) emerged as a potential mediator of MVA pathway signaling to mTOR. Here, we investigated the therapeutic efficacy of additional MVA pathway inhibitors and the role of YAP/TAZ in mediating resistance to HER2-targeted therapy.
Methods: HER2+ SKBR3 and AU565 BC cells and their LTR derivatives were used. Changes in cell growth upon genetic and pharmacologic inhibition of the MVA pathway were quantified by methylene blue staining. Luciferase reporter assays and western blots (WB) measured changes in total and phosphorylated (S127 and S381/inactive) YAP protein levels to examine activity of the YAP/TAZ TF complex. To validate the function of YAP/TAZ in resistance, we performed YAP/TAZ knockdown (siRNA), overexpression of dominant-active YAP constructs (S381A, S381/127A), and qRT-PCR assessment of YAP/TAZ target gene expression.
Results: ZA, like simvastatin (Sim), selectively inhibited the growth of resistant cells in a dose-dependent manner. This inhibition was rescued by geranyl geranyl pyrophosphate (GGPP), a downstream metabolite, but not by MVA, an upstream metabolite, indicating the on-target effect of ZA. Further, ZA and Sim combination showed a synergistic growth-inhibitory effect in R but not in parental (P) cells. YAP/TAZ luciferase reporter assays and phosphorylated YAP and total TAZ levels by WB, confirmed the increased activity of YAP/TAZ in R models, which was selectively inhibited by Sim or ZA and was rescued by the corresponding downstream metabolites. YAP/TAZ knockdown selectively inhibited resistant cell growth and mTOR signaling in R vs. P cells, and dominant-active YAP/TAZ rescued the mTOR inhibition by Sim. YAP/TAZ inhibition by siRNA or by Sim significantly decreased the expression of YAP/TAZ target gene survivin in R vs. P cells, and the Sim inhibition was rescued by MVA.
Conclusions: The MVA pathway plays a critical role in mediating resistance to anti-HER2 therapy, which was overcome by Sim and ZA either alone or in combination. Given the synergistic effect of Sim and ZA, their combination may offer a therapeutic strategy to overcome HER2-targeted therapy resistance. Our results also reveal the role of YAP/TAZ in MVA pathway-mediated HER2-targeted therapy resistance, which could suggest new biomarkers and therapeutic targets.
Citation Format: Sethunath V, Hu H, De Angelis C, Veeraraghavan J, Qin L, Rimawi MF, Osborne KC, Schiff R. Targeting the mevalonate pathway in HER2-positive breast cancer to overcome resistance to anti-HER2 therapy [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-03-04.
Collapse
Affiliation(s)
| | - H Hu
- Baylor College of Medicine, Houston, TX
| | | | | | - L Qin
- Baylor College of Medicine, Houston, TX
| | - MF Rimawi
- Baylor College of Medicine, Houston, TX
| | | | - R Schiff
- Baylor College of Medicine, Houston, TX
| |
Collapse
|
225
|
Liu J, Lichtenberg T, Hoadley KA, Cherniack A, Poisson L, Kovatich AJ, Benz C, Thorsson V, Shriver CD, Hu H. Abstract P3-16-01: Using the new pan-cancer clinical data resource (TCGA-CDR) to identify breast cancer genomic correlates associating with different survival outcome endpoints. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p3-16-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction The Cancer Genome Atlas (TCGA) generated abundant high quality molecular data, however its relatively short-term patient follow-up limited its immediate clinical utility. We led a PanCanAtlas effort to systematically collate, integrate, and quality check the large body of acquired clinicopathologic data, generated 4 primary clinical outcome endpoints for each case, and created a new Pan-Cancer Clinical Data Resource (TCGA-CDR) for public use. We report here on the utility and validity of this TCGA-CDR in relating breast cancer (BC) genomic information to survival endpoints.
Methods Clinicopathologic data from all data files were integrated and processed. Overall survival (OS), disease-specific survival (DSS, an approximation), progression-free interval (PFI), and disease-free interval (DFI)were derived.Tests of the adequacy of the follow-up intervals for each endpoint were performed, and quality evaluation of these endpoints was established by their comparison with different clinical features. As a case study we compared each survival endpoint for significant association (FDR <0.2) with chromosomal aneuploidy.
Results The 4 endpoints were derived for 1097 TCGA BC cases having a median follow-up time of 27.7 months. Median times to events/censorship for OS, DSS, PFI, and DFI were 41.8/25.0, 32.6/26.0, 26.0/25.0, and 25.4/25.0 months respectively. PFI and DFI passed tests for adequate follow-up times; OS and DSS partially passed the same tests signaling some caution with their use in genomic associations.
Using the endpoints, outcomes of patients with ER+ and ER- tumors were compared, along with those of patients with low (I&II) and high (III&IV) stage breast tumors. Univariate analyses suggested patients with ER+ tumors had significantly better survival than patients with ER- tumors when using PFI (p=0.005), DFI (p=0.001), and DSS (p=0.009), with OS not reaching significance (p=0.09). Patients with low stage tumors showed significantly better outcomes than patients with high stage tumors for each endpoint (p<0.001). The 4 endpoints were also evaluated for their significant associations with chromosomal arm aneuploidy. Adjusted for patient age and AJCC stage, tumors with a loss of 8q and 8p (p=0.019, FDR=0.37) had worse PFI; and those with loss of 8q, 20q, and 8p had worse DFI. Tumors with gain of 11q or loss of 14, 7q, 12q, 18q, 20q, 3p, 7p, 8p, 18p, and 20p had worse OS. In contrast, tumors with loss of 16q had better DSS, while those with loss of 3q, 12q, 17q, 18q, 19q, 20q, 3p, 8p, 12p, 18p, 19p, and 20p had worse DSS. The finding that 8p loss associated with worse survival for all 4 endpoints, while 18p loss associated with worse OS and DSS, agrees with literature reports.
Conclusion These findings confirm that PFI and DFI, as extracted from the TCGA-CDR, are valid and appropriate BC survival endpoints, while OS and DSS may be recommended with some caution when employing TCGA data to evaluate new relationships between breast cancer genomic abnormalities and clinical outcomes.
The views expressed in this article are those of the author and do not reflect the official policy of the Department of Army/Navy/Air Force, the Department of Defense, or U.S. Government.
Citation Format: Liu J, Lichtenberg T, Hoadley KA, Cherniack A, Poisson L, Kovatich AJ, Benz C, Thorsson V, TCGA PanCanAtlas Research Network, Shriver CD, Hu H. Using the new pan-cancer clinical data resource (TCGA-CDR) to identify breast cancer genomic correlates associating with different survival outcome endpoints [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P3-16-01.
Collapse
Affiliation(s)
- J Liu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - T Lichtenberg
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - KA Hoadley
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - A Cherniack
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - L Poisson
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - AJ Kovatich
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - C Benz
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - V Thorsson
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - CD Shriver
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | - H Hu
- Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA; Nationwide Children's Hospital, Columbus, OH; University of North Carolina at Chapel Hill, Chapel Hill, NC; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA; Henry Ford Health System, Detroit, MI; Clinical Breast Care Project, Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD; Buck Institute for Research on Aging, Novato, CA; Institute for Systems Biology, Seattle, WA; Murtha Cancer Center, Uniformed Services University / Walter Reed National Military Medical Center, Bethesda, MD
| | | |
Collapse
|
226
|
Lü Y, Liu W, Liang H, Zhao S, Zhang W, Liu J, Jin C, Hu H. NDM-1 encoded by a pNDM-HN380-like plasmid pNDM-BJ03 in clinical Enterobacter cloacae. Diagn Microbiol Infect Dis 2018; 90:153-155. [DOI: 10.1016/j.diagmicrobio.2017.10.022] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2017] [Revised: 09/26/2017] [Accepted: 10/31/2017] [Indexed: 11/30/2022]
|
227
|
Arciero C, Somiari S, Shriver C, Brzeski H, Jordan R, Hu H, Ellsworth D, Somiari R. Functional Relationship and Gene Ontology Classification of Breast Cancer Biomarkers. Int J Biol Markers 2018. [DOI: 10.1177/172460080301800403] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Breast cancer is a complex disease that still imposes a significant healthcare burden on women worldwide. The etiology of breast cancer is not known but significant advances have been made in the area of early detection and treatment. The advent of advanced molecular biology techniques, mapping of the human genome and availability of high throughput genomic and proteomic strategies opens up new opportunities and will potentially lead to the discovery of novel biomarkers for early detection and prognostication of breast cancer. Currently, many biomarkers, particularly the hormonal and epidermal growth factor receptors, are being utilized for breast cancer prognosis. Unfortunately, none of the biomarkers in use have sufficient diagnostic, prognostic and/or predictive power across all categories and stages of breast cancer. It is recognized that more useful information can be generated if tumors are interrogated with multiple markers. But choosing the right combination of biomarkers is challenging, because 1) multiple pathways are involved, 2) up to 62 genes and their protein products are potentially involved in breast cancer-related mechanisms and 3) the more markers evaluated, the more the time and cost involved. This review summarizes the current literature on selected biomarkers for breast cancer, discusses the functional relationships, and groups the selected genes based on a Gene Ontology™ classification.
Collapse
Affiliation(s)
- C. Arciero
- General Surgery Services, Walter Reed Army Medical Center, Washington DC
- Windber Research Institute, Windber PA - USA
| | | | - C.D. Shriver
- General Surgery Services, Walter Reed Army Medical Center, Washington DC
| | - H. Brzeski
- Windber Research Institute, Windber PA - USA
| | - R. Jordan
- Windber Research Institute, Windber PA - USA
| | - H. Hu
- Windber Research Institute, Windber PA - USA
| | | | | |
Collapse
|
228
|
Abstract
Vertically-oriented PtO nanowires have been selectively grown on ZnO nanowire arrays for the first time by a light-controlled method and were utilized as highly efficient OER cocatalysts for remarkably enhancing the PEC performance of water splitting.
Collapse
Affiliation(s)
- Shurong Fu
- State Key Laboratory for Oxo Synthesis & Selective Oxidation
- National Engineering Research Center for Fine Petrochemical Intermediates
- Lanzhou Institute of Chemical Physics, CAS
- Lanzhou
- China
| | - Beibei Zhang
- State Key Laboratory for Oxo Synthesis & Selective Oxidation
- National Engineering Research Center for Fine Petrochemical Intermediates
- Lanzhou Institute of Chemical Physics, CAS
- Lanzhou
- China
| | - Hongyan Hu
- State Key Laboratory for Oxo Synthesis & Selective Oxidation
- National Engineering Research Center for Fine Petrochemical Intermediates
- Lanzhou Institute of Chemical Physics, CAS
- Lanzhou
- China
| | - Yajun Zhang
- State Key Laboratory for Oxo Synthesis & Selective Oxidation
- National Engineering Research Center for Fine Petrochemical Intermediates
- Lanzhou Institute of Chemical Physics, CAS
- Lanzhou
- China
| | - Yingpu Bi
- State Key Laboratory for Oxo Synthesis & Selective Oxidation
- National Engineering Research Center for Fine Petrochemical Intermediates
- Lanzhou Institute of Chemical Physics, CAS
- Lanzhou
- China
| |
Collapse
|
229
|
Sun K, Hu H, Yang C, Wang L, Ai Y, Dong X, Shi Y, Li M, Yao Q, Zhang Y. Dietary Intake is Positively Associated with Cognitive Function of a Chinese Older Adults Sample. J Nutr Health Aging 2018; 22:805-810. [PMID: 30080224 DOI: 10.1007/s12603-018-1048-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE The relationship between cognitive function and dietary intake in older adults was under-studied in China. This study examined this relationship in a Chinese sample while controlling for the effects of sleep quality and socio demographic confounders. METHODS The sample consisted of 340 Chinese older adults (age > 60) who were randomly selected from Wuhan city in central China. Cognitive function was assessed by the Mini-mental State Examination [MMSE], sleep quality by the Pittsburgh Sleep Quality Index [PSQI], and dietary intake by frequencies of intake of meat products, fruits, fish/seafood/aquatic products, nuts and mushroom/algae over the past year. First, confirmatory factor analysis (CFA) was conducted to evaluate the measurement properties of cognitive function, dietary intake, and sleep quality. Second, structural equation modeling (SEM) was conducted to examine the relations of cognitive function, dietary intake, and sleep quality. RESULTS Dietary intake was found to be positively related to cognitive function. Older age, lower education status, monthly income, and living alone or without a spouse were significantly associated with poorer cognitive function. SES status had an indirect effect on cognitive function via dietary intake. CONCLUSION Dietary intake may be critical to maintain normal cognitive function of older adults in China.
Collapse
Affiliation(s)
- K Sun
- Hui Hu, College of Nursing, Hubei University of Chinese Medicine, No. 1 Huangjiahu West Street, Wuhan 430065, China; , Tel.: +86-27-68890390
| | | | | | | | | | | | | | | | | | | |
Collapse
|
230
|
Hu H, Wang J, Han X, Li Y, Wang F, Yuan J, Miao X, Yang H, He M. BMI, Waist Circumference and All-Cause Mortality in a Middle-Aged and Elderly Chinese Population. J Nutr Health Aging 2018; 22:975-981. [PMID: 30272102 DOI: 10.1007/s12603-018-1047-z] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To investigate the association of obesity and all-cause mortality in a sample of middle-aged and elderly population. DESIGN AND SETTING Information of participants was collected in the Dongfeng-Tongji study, a perspective cohort study of Chinese occupational population. The main outcome was risk of death after 8.5 years of follow-up. PARTICIPANTS AND MEASUREMENTS We examined the association of BMI, waist circumference (WC, and waist-height ratio (WHtR) with all-cause mortality in the Dongfeng-Tongji cohort study (n=26,143). Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI) for all-cause mortality. Area under the receiver operating characteristic curves and net reclassification improvement (NRI) were used to calculate the power of prediction models. RESULTS During a mean of 8.5 years of follow-up, 2,246 deaths were identified. There is a U-shaped association of BMI with all-cause mortality in the middle-aged and elderly Chinese population. Compared with individuals with normal BMI, underweight was positively (HR=2.16, 95% CI: 1.73, 2.69) while overweight (HR=0.75, 95% CI: 0.67, 0.84) and obesity (HR=0.67, 95% CI: 0.56, 0.79) were negatively associated with all-cause mortality after adjustment for potential confounders including WC. In contrast, WC (Q5 vs. Q1, HR=1.55, 95% CI: 1.29, 1.86) and WHtR (Q5 vs.Q1, HR=1.69, 95% CI: 1.40, 2.04) were positively associated with mortality after further adjustment for BMI (P trend < 0.001). Addition of both BMI and WC into the all-cause mortality predictive model significantly increased AUC (P =0.0002) and NRI (NRI = 2.57%, P = 0.0007). CONCLUSIONS BMI and WC/WHtR were independently associated with all-cause mortality after mutual adjustment. Combination of BMI and WC/WHtR improved the predictive ability of all-cause mortality risk in the middle-aged and elderly population.
Collapse
Affiliation(s)
- H Hu
- Meian He, MD, PhD, Professor, Department of Occupational and Environmental Health and State Key Laboratory of Environmental Health for Incubating, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei 430030, China. Tel: 86-27-83657914; Fax: 86-27-83657765; E-mail:
| | | | | | | | | | | | | | | | | |
Collapse
|
231
|
Deshmukh V, Hu H, Barroga C, Bossard C, Kc S, Dellamary L, Stewart J, Chiu K, Ibanez M, Pedraza M, Seo T, Do L, Cho S, Cahiwat J, Tam B, Tambiah JRS, Hood J, Lane NE, Yazici Y. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2018; 26:18-27. [PMID: 28888902 DOI: 10.1016/j.joca.2017.08.015] [Citation(s) in RCA: 144] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2017] [Revised: 07/18/2017] [Accepted: 08/30/2017] [Indexed: 02/02/2023]
Abstract
OBJECTIVES Osteoarthritis (OA) is a degenerative disease characterized by loss of cartilage and increased subchondral bone within synovial joints. Wnt signaling affects the pathogenesis of OA as this pathway modulates both the differentiation of osteoblasts and chondrocytes, and production of catabolic proteases. A novel small-molecule Wnt pathway inhibitor, SM04690, was evaluated in a series of in vitro and in vivo animal studies to determine its effects on chondrogenesis, cartilage protection and synovial-lined joint pathology. DESIGN A high-throughput screen was performed using a cell-based reporter assay for Wnt pathway activity to develop a small molecule designated SM04690. Its properties were evaluated in bone-marrow-derived human mesenchymal stem cells (hMSCs) to assess chondrocyte differentiation and effects on cartilage catabolism by immunocytochemistry and gene expression, and glycosaminoglycan breakdown. In vivo effects of SM04690 on Wnt signaling, cartilage regeneration and protection were measured using biochemical and histopathological techniques in a rodent acute cruciate ligament tear and partial medial meniscectomy (ACLT + pMMx) OA model. RESULTS SM04690 induced hMSC differentiation into mature, functional chondrocytes and decreased cartilage catabolic marker levels compared to vehicle. A single SM04690 intra-articular (IA) injection was efficacious in a rodent OA model, with increased cartilage thickness, evidence for cartilage regeneration, and protection from cartilage catabolism observed, resulting in significantly improved Osteoarthritis Research Society International (OARSI) histology scores and biomarkers, compared to vehicle. CONCLUSIONS SM04690 induced chondrogenesis and appeared to inhibit joint destruction in a rat OA model, and is a candidate for a potential disease modifying therapy for OA.
Collapse
Affiliation(s)
| | - H Hu
- Samumed, LLC, San Diego, CA, USA.
| | | | | | - S Kc
- Samumed, LLC, San Diego, CA, USA.
| | | | | | - K Chiu
- Samumed, LLC, San Diego, CA, USA.
| | - M Ibanez
- Samumed, LLC, San Diego, CA, USA.
| | | | - T Seo
- Samumed, LLC, San Diego, CA, USA.
| | - L Do
- Samumed, LLC, San Diego, CA, USA.
| | - S Cho
- Samumed, LLC, San Diego, CA, USA.
| | | | - B Tam
- Samumed, LLC, San Diego, CA, USA.
| | | | - J Hood
- Samumed, LLC, San Diego, CA, USA.
| | - N E Lane
- University of California, Davis, CA, USA.
| | - Y Yazici
- Samumed, LLC, San Diego, CA, USA.
| |
Collapse
|
232
|
Fan K, Jin Z, Wang G, Yang H, Liu D, Hu H, Lu G, Bi Y. Distinctive organized molecular assemble of MoS2, MOF and Co3O4, for efficient dye-sensitized photocatalytic H2 evolution. Catal Sci Technol 2018. [DOI: 10.1039/c8cy00380g] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Stable and efficient photocatalyst has been a key research goal in recent years.
Collapse
Affiliation(s)
- Kai Fan
- School of Chemistry and Chemical Engineering
- North Minzu University
- Yinchuan 750021
- P.R. China
| | - Zhiliang Jin
- School of Chemistry and Chemical Engineering
- North Minzu University
- Yinchuan 750021
- P.R. China
| | - Guorong Wang
- School of Chemistry and Chemical Engineering
- North Minzu University
- Yinchuan 750021
- P.R. China
| | - Hao Yang
- School of Chemistry and Chemical Engineering
- North Minzu University
- Yinchuan 750021
- P.R. China
| | - Duanduan Liu
- School of Chemistry and Chemical Engineering
- North Minzu University
- Yinchuan 750021
- P.R. China
| | - Hongyan Hu
- State Key Laboratory for Oxo Synthesis and Selective Oxidation
- Lanzhou Institute of Chemical Physics, Chinese Academy of Science
- Lanzhou 730000
- P.R. China
| | - Gongxuan Lu
- State Key Laboratory for Oxo Synthesis and Selective Oxidation
- Lanzhou Institute of Chemical Physics, Chinese Academy of Science
- Lanzhou 730000
- P.R. China
| | - Yingpu Bi
- State Key Laboratory for Oxo Synthesis and Selective Oxidation
- Lanzhou Institute of Chemical Physics, Chinese Academy of Science
- Lanzhou 730000
- P.R. China
| |
Collapse
|
233
|
Fan K, Jin Z, Yuan H, Hu H, Bi Y. Construction of CuO-modified zeolitic imidazolate framework-9 for photocatalytic hydrogen evolution. Chinese Journal of Catalysis 2017. [DOI: 10.1016/s1872-2067(17)62969-3] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
234
|
Hu H, Pereira J, Xing L, Zhou G, Zhang W. Thermal gelation and microstructural properties of myofibrillar protein gel with the incorporation of regenerated cellulose. Lebensm Wiss Technol 2017. [DOI: 10.1016/j.lwt.2017.07.015] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
235
|
Zhang C, Yuan J, Hu H, Chen W, Liu M, Zhang J, Sun S, Guo Z. Long non-coding RNA CHCHD4P4 promotes epithelial-mesenchymal transition and inhibits cell proliferation in calcium oxalate-induced kidney damage. ACTA ACUST UNITED AC 2017; 51:e6536. [PMID: 29160413 PMCID: PMC5685061 DOI: 10.1590/1414-431x20176536] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2017] [Accepted: 08/17/2017] [Indexed: 02/06/2023]
Abstract
Kidney stone disease is a major cause of chronic renal insufficiency. The role of long non-coding RNAs (lncRNAs) in calcium oxalate-induced kidney damage is unclear. Therefore, we aimed to explore the roles of lncRNAs in glyoxylate-exposed and healthy mouse kidneys using microarray technology and bioinformatics analyses. A total 376 mouse lncRNAs were differentially expressed between the two groups. Using BLAST, 15 lncRNA homologs, including AU015836 and CHCHD4P4, were identified in mice and humans. The AU015836 expression in mice exposed to glyoxylate and the CHCHD4P4 expression in human proximal tubular epithelial (HK-2) cells exposed to calcium oxalate monohydrate were analyzed, and both lncRNAs were found to be upregulated in response to calcium oxalate. To further evaluate the effects of CHCHD4P4 on the cell behavior, we constructed stable CHCHD4P4-overexpressing and CHCHD4P4-knockdown HK-2 cells. The results showed that CHCHD4P4 inhibited cell proliferation and promoted the epithelial-mesenchymal transition in kidney damage and fibrosis caused by calcium oxalate crystallization and deposition. The silencing of CHCHD4P4 reduced the kidney damage and fibrosis and may thus be a potential molecular target for the treatment of kidney stones.
Collapse
Affiliation(s)
- C Zhang
- Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - J Yuan
- Department of Medical Genetics, Second Military Medical University, Shanghai, China
| | - H Hu
- Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - W Chen
- Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - M Liu
- Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - J Zhang
- Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - S Sun
- Department of Medical Genetics, Second Military Medical University, Shanghai, China
| | - Z Guo
- Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, China
| |
Collapse
|
236
|
Cai W, Hu H. The metastases spectrum of neuroendocrine neoplasms in gastrointestinal tract. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx660.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
237
|
Hu H, Cai W, Ge W. SPARCL1, a novel prognostic predictive factor for GI malignancies: A meta-analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx653.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
238
|
Lv T, Hu H, Liu H, Song Y. P2.01-019 The Necessity of Contrast-enhanced CT before CT-Guided Percutaneous Transthoracic Needle Biopsy for Lung Lesions. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
239
|
Kato T, Jin C, Ujiie H, Lee D, Kosuke F, Wada H, Hu H, Weersink R, Chen J, Kaji M, Wilson B, Zheng G, Kaga K, Matsui Y, Yasufuku K. P1.12-002 Nanoparticle Targeted Folate Receptor 1 Enhanced Photodynamic Therapy for Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
240
|
Ding Y, Guan X, Zhu X, Hu H, Bozhevolnyi SI, Oxenløwe LK, Jin KJ, Mortensen NA, Xiao S. Efficient electro-optic modulation in low-loss graphene-plasmonic slot waveguides. Nanoscale 2017; 9:15576-15581. [PMID: 28984878 DOI: 10.1039/c7nr05994a] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Surface plasmon polaritons enable light concentration within subwavelength regions, opening thereby new avenues for miniaturizing the device and strengthening light-matter interactions. Here we realize efficient electro-optic modulation in low-loss plasmonic waveguides with the aid of graphene, and the devices are fully integrated in the silicon-on-insulator platform. By advantageously exploiting low-loss plasmonic slot-waveguide modes, which weakly leak into a substrate while featuring strong fields within the two-layer-graphene covered slots in metals, we successfully achieve a tunability of 0.13 dB μm-1 for our fabricated graphene-plasmonic waveguide devices with extremely low insertion loss, which outperforms previously reported graphene-plasmonic devices. Our results highlight the potential of graphene plasmonic leaky-mode hybrid waveguides to realize active ultra-compact devices for optoelectronic applications.
Collapse
Affiliation(s)
- Y Ding
- Department of Photonics Engineering, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
| | | | | | | | | | | | | | | | | |
Collapse
|
241
|
Zhang WY, Hu H, Zhang XP, Sun YR, Wang HR, Xu KX. [Comparison and discussion of different surgical methods used to treat vesicovaginal fistulas]. Beijing Da Xue Xue Bao Yi Xue Ban 2017; 49:889-892. [PMID: 29045975] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVE To compare the feasibility and prognosis of different surgical methods used for vesicovaginal fistulas and to explore the value of electrocoagulation treating small ones. METHODS The medical data of 19 patients who had undertaken transvaginal VVF repairs in Peking University People's Hospital between October 2008 and November 2016 were retrospectively collected. The follow-ups were performed. The patients' age ranged from 31 to 55 years with the median age of 48 years and the history length ranged from 1 month to 24 months with the median length of 3 months. Their fistula situation, surgical methods and prognosis were analyzed and the differences and similarities were compared. RESULTS Three patients (15.79%) was performed by electrocoagulation, 4 (21.05%) by transvaginal repair, 5 (21.32%) by laparoscopic repair and 7(36.84%) by open operation. Except one patient who rejected urinary catheter and D-J catheters, the rest of the patients discharged with catheters. Twelve patients (63.2%) got full satisfaction with one operation. One of the 3 patients who undertook electrocoagulation repeated the operation for twice and got completely cured within 1 month while the other two undertook the operation once and got dry within 1 month. Three patients who undertook transvaginal repair got dry within 1 month. Two of the 5 patients who undertook laparoscopic repair had readmission for a second operation and the other 3 got dry after operation. Five of the 7 open repair patients got dry while the other 2 attempted other center for treatment. CONCLUSION Transvaginal repair has been the main surgery procedure for VVF, but it is limited by the location of fistula and the condition of vaginal. For patients not suitable for transvaginal repair, laparoscopic repair and open surgery are feasible. However both laparoscopic repair and open surgery are more invasive. Based on that, electrocoagulation becomes a better choice. In our research, patients with small and high location fistula treated by electrocoagulation got a higher cure rate and bear less surgical trauma. Electrocoagulation used in the treatment of VVF showed advantages of less trauma, less bleeding and better satisfaction. Fistulas with low location were more suitable for transvaginal repair. Complex VVF, especially with narrow ureteral open and ureteral fistulas, were more suitable for open and laparoscopic repair. As for single and small fistula, the electrocoagulation can be the first choice.
Collapse
Affiliation(s)
- W Y Zhang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - H Hu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - X P Zhang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - Y R Sun
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - H R Wang
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| | - K X Xu
- Department of Urology, Peking University People's Hospital, Beijing 100044, China
| |
Collapse
|
242
|
Han T, Hu H, Zhuo M, Wang L, Cui JJ, Jiao F, Wang LW. Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer. Curr Mol Med 2017; 16:702-709. [PMID: 27686798 DOI: 10.2174/1566524016666160927095812] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2016] [Revised: 09/06/2016] [Accepted: 09/07/2016] [Indexed: 11/22/2022]
Abstract
Pancreatic cancer remains a worldwide issue and burden that is hard to resolve given its low resection rate and chemo-resistance. Early diagnosis and early treatment are critical for conquering pancreatic cancer. Therefore, new biomarkers for diagnosis and prognosis are urgently needed. Previously, researchers mainly focused on protein-coding genetic and epigenetic changes in many types of cancers, and regarded the noncoding part as waste. Recently, however, long non-coding RNA (lncRNA) has emerged as a major participant in carcinogenesis, as it regulates cell proliferation, migration, invasion, metastasis, chemo-resistance, etc. The underlying mechanisms are summarized as signaling, decoy, guide and scaffold, yet the specific regulation networks remain to be uncovered. Several studies have revealed that some lncRNAs are dysregulated in pancreatic cancer, participating in biological functions. In this review, we will briefly outline the functional lncRNAs in pancreatic cancer, decipher possible mechanisms of lncRNAs, and further explore their significance in pancreatic cancer.
Collapse
Affiliation(s)
| | | | | | | | | | - F Jiao
- Department of Medical Oncology and Pancreatic Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Pancreatic Diseases, 650 New Songjiang Road, Shanghai 201620, China.
| | | |
Collapse
|
243
|
Hibberd TJ, Costa M, Travis L, Brookes SJH, Wattchow DA, Feng J, Hu H, Spencer NJ. Neurogenic and myogenic patterns of electrical activity in isolated intact mouse colon. Neurogastroenterol Motil 2017; 29:1-12. [PMID: 28418103 DOI: 10.1111/nmo.13089] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Accepted: 03/16/2017] [Indexed: 01/02/2023]
Abstract
BACKGROUND Relatively little is known about the electrical rhythmicity of the whole colon, where long neural pathways are preserved. METHODS Smooth muscle electrical activity was recorded extracellularly from the serosa of isolated flat-sheet preparations consisting of the whole mouse colon (n=31). KEY RESULTS Two distinct electrical patterns were observed. The first, long intense spike bursts, occurred every 349±256 seconds (0.2±0.2 cpm), firing action potentials for 31±11 seconds at 2.1±0.5 Hz. They were hexamethonium- and tetrodotoxin-sensitive, but persisted in nicardipine as 2 Hz electrical oscillations lacking action potentials. This pattern is called here neurogenic spike bursts. The second pattern, short spike bursts, occurred about every 30 seconds (2.0±0.6 cpm), with action potentials firing at about 1 Hz for 9 seconds (1.0±0.2 Hz, 9±4 seconds). Short spike bursts were hexamethonium- and tetrodotoxin-resistant but nicardipine-sensitive and thus called here myogenic spike bursts. Neurogenic spike bursts transiently delayed myogenic spike bursts, while blocking neurogenic activity enhanced myogenic spike burst durations. External stimuli significantly affected neurogenic but not myogenic spike bursts. Aboral electrical or mechanical stimuli evoked premature neurogenic spike bursts. Circumferential stretch significantly decreased intervals between neurogenic spike bursts. Lesioning the colon down to 10 mm segments significantly increased intervals or abolished neurogenic spike bursts, while myogenic spike bursts persisted. CONCLUSIONS & INFERENCES Distinct neurogenic and myogenic electrical patterns were recorded from mouse colonic muscularis externa. Neurogenic spike bursts likely correlate with neurogenic colonic migrating motor complexes (CMMC) and are highly sensitive to mechanical stimuli. Myogenic spike bursts may correspond to slow myogenic contractions, whose duration can be modulated by enteric neural activity.
Collapse
Affiliation(s)
- T J Hibberd
- Discipline of Human Physiology & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| | - M Costa
- Discipline of Human Physiology & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| | - L Travis
- Discipline of Human Physiology & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| | - S J H Brookes
- Discipline of Human Physiology & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| | - D A Wattchow
- Discipline of Surgery & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| | - J Feng
- Department of Anesthesiology, The Center for the Study of Itch, Washington University School of Medicine, St. Louis, MO, USA
| | - H Hu
- Department of Anesthesiology, The Center for the Study of Itch, Washington University School of Medicine, St. Louis, MO, USA
| | - N J Spencer
- Discipline of Human Physiology & Centre for Neuroscience, Flinders University, Adelaide, SA, Australia
| |
Collapse
|
244
|
Xu XQ, Qian W, Ma G, Hu H, Su GY, Liu H, Shi HB, Wu FY. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses. Clin Radiol 2017; 72:903.e9-903.e15. [PMID: 28501096 DOI: 10.1016/j.crad.2017.04.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Revised: 03/30/2017] [Accepted: 04/10/2017] [Indexed: 11/29/2022]
Abstract
AIM To evaluate the performance of the combination of diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for differentiating radiologically indeterminate malignant from benign orbital masses. MATERIALS AND METHODS Sixty-five patients with orbital masses (36 benign and 29 malignant) underwent DW and DCE MRI examinations for pre-treatment evaluation. The apparent diffusion coefficient (ADC) was derived from DW imaging data using the mono-exponential model. The volume transfer constant (Ktrans), the flux rate constant between the extravascular extracellular space and the plasma (Kep), and the extravascular extracellular volume fraction (Ve) were calculated using modified Tofts model. Differences in quantitative metrics were tested using independent-samples t test. Receiver operating characteristic (ROC) curve analyses were used to determine and compare the diagnostic ability of each significant metric. RESULTS The malignant group demonstrated significantly lower ADC (0.711±0.260 versus 1.187±0.389, p<0.001) and higher Kep values (1.265±0.637 versus 0.871±0.610, p=0.008) than the benign group. Optimal diagnostic performance (area under the ROC curve [AUC], 0.941; sensitivity, 0.966; specificity, 0.917) could be achieved using combined ADC and Kep values as the diagnostic index. The diagnostic performance of the combination of ADC and Kep was significantly better than Kep alone (p=0.006). Compared with ADC alone, combined ADC and Kep values also showed higher AUC (0.941 versus 0.898), although the difference did not reach statistical significance (p=0.220). CONCLUSION Kep and ADC could help to differentiate radiologically indeterminate malignant from benign orbital masses. The combination of DW and DCE MRI might improve the differentiating performance.
Collapse
Affiliation(s)
- X-Q Xu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - W Qian
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - G Ma
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - H Hu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - G-Y Su
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - H Liu
- Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - H-B Shi
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - F-Y Wu
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
| |
Collapse
|
245
|
Zhou QS, Hu J, Hu H. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs. Eur Rev Med Pharmacol Sci 2017; 21:4423-4430. [PMID: 29077150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVE To investigate the therapeutic effect of drug therapy with cyclophosphamide and leflunomide on the joint function damage of patients with systemic lupus erythematosus (SLE) and its regulatory effects on expression levels of programmed death receptor 1, Notch signaling pathway genes and interferon-inducible protein 10 in peripheral blood mononuclear cells. PATIENTS AND METHODS A total of 60 patients with SLE were randomly divided into two groups. They were treated with cyclophosphamide and leflunomide, respectively. The number of painful joints, joint tenderness index, joint swelling index and erythrocyte sedimentation rate of patients before and after treatment were evaluated, and the peripheral blood was collected from patients in the two groups; the peripheral blood mononuclear cells were extracted. RESULTS We observed that the number of painful joints, joint tenderness index and joint swelling index in cyclophosphamide group were decreased after treatment (p<0.05), and the erythrocyte sedimentation rate was significantly decreased (p<0.05). The number of painful joints, joint tenderness index and joint swelling index in leflunomide group were decreased after treatment (p<0.05), and the erythrocyte sedimentation rate was significantly decreased (p<0.05). The comparisons of changes in joint functions and erythrocyte sedimentation rates between cyclophosphamide group and leflunomide group after drug therapy showed that the curative effect in leflunomide group was superior to that in cyclophosphamide group (p<0.05). The positive expression rate of peripheral blood mononuclear cell Notch1 in leflunomide group after treatment was significantly decreased, and the curative effect was superior to that in cyclophosphamide group (p<0.05). The comparisons of changes in programmed death receptor 1 of lymphocytes and interferon-inducible protein 10 between cyclophosphamide group and leflunomide group after drug therapy showed that the curative effect in leflunomide group was superior to that in cyclophosphamide group (p<0.05). The comparison of positive expression rate of nuclear factor-κB (NF-κB) in peripheral blood mononuclear cells between the two groups after treatment showed that the curative effect in leflunomide group was superior to that in cyclophosphamide group (p<0.05). There were positive correlations of the expression level of programmed death receptor 1 of peripheral blood lymphocytes in SLE patients with double-stranded DNA (ds-DNA) and SLE disease activity index (p<0.05). There were positive correlations of the expression level of peripheral interferon-inducible protein 10 in SLE patients with ds-DNA and SLE disease activity index (p<0.05). CONCLUSIONS This study proved that both leflunomide and cyclophosphamide have therapeutic effects on the joint functions and immune dysfunction of peripheral blood mononuclear cells of SLE patients; however, and the effect of leflunomide is better. There are positive correlations of SLE disease activity index with the Notch signaling pathway genes, programmed death receptor 1 and interferon-inducible protein 10 in peripheral blood mononuclear cells, suggesting that these factors are related to the immune dysfunction of peripheral blood mononuclear cells.
Collapse
Affiliation(s)
- Q-S Zhou
- Department of Rheumatism, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, Jiangsu Province, China.
| | | | | |
Collapse
|
246
|
Almatroudi A, Tahir S, Hu H, Chowdhury D, Gosbell IB, Jensen SO, Whiteley GS, Deva AK, Glasbey T, Vickery K. Staphylococcus aureus dry-surface biofilms are more resistant to heat treatment than traditional hydrated biofilms. J Hosp Infect 2017; 98:161-167. [PMID: 28919336 DOI: 10.1016/j.jhin.2017.09.007] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2017] [Accepted: 09/11/2017] [Indexed: 01/07/2023]
Abstract
BACKGROUND The importance of biofilms to clinical practice is being increasingly realized. Biofilm tolerance to antibiotics is well described but limited work has been conducted on the efficacy of heat disinfection and sterilization against biofilms. AIM To test the susceptibility of planktonic, hydrated biofilm and dry-surface biofilm forms of Staphylococcus aureus, to dry-heat and wet-heat treatments. METHODS S. aureus was grown as both hydrated biofilm and dry-surface biofilm in the CDC biofilm generator. Biofilm was subjected to a range of temperatures in a hot-air oven (dry heat), water bath or autoclave (wet heat). FINDINGS Dry-surface biofilms remained culture positive even when treated with the harshest dry-heat condition of 100°C for 60min. Following autoclaving samples were culture negative but 62-74% of bacteria in dry-surface biofilms remained alive as demonstrated by live/dead staining and confocal microscopy. Dry-surface biofilms subjected to autoclaving at 121°C for up to 30min recovered and released planktonic cells. Recovery did not occur following autoclaving for longer or at 134°C, at least during the time-period tested. Hydrated biofilm recovered following dry-heat treatment up to 100°C for 10min but failed to recover following autoclaving despite the presence of 43-60% live cells as demonstrated by live/dead staining. CONCLUSION S. aureus dry-surface biofilms are less susceptible to killing by dry heat and steam autoclaving than hydrated biofilms, which are less susceptible to heat treatment than planktonic suspensions.
Collapse
Affiliation(s)
- A Almatroudi
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia; Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Qassim, Saudi Arabia
| | - S Tahir
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia
| | - H Hu
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia
| | - D Chowdhury
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia
| | - I B Gosbell
- Antibiotic Resistance and Mobile Elements Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; Medical Sciences Research Group, School of Medicine, Western Sydney University, New South Wales, Australia; Department of Microbiology & Infectious Diseases, Sydney South West Pathology Service, Liverpool, New South Wales Health Pathology, New South Wales, Australia
| | - S O Jensen
- Antibiotic Resistance and Mobile Elements Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia; Medical Sciences Research Group, School of Medicine, Western Sydney University, New South Wales, Australia
| | - G S Whiteley
- Medical Sciences Research Group, School of Medicine, Western Sydney University, New South Wales, Australia; Whiteley Corporation, North Sydney, New South Wales, Australia
| | - A K Deva
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia
| | - T Glasbey
- Whiteley Corporation, North Sydney, New South Wales, Australia
| | - K Vickery
- Surgical Infection Research Group, Faculty of Medicine and Health Sciences, Macquarie University, New South Wales, Australia.
| |
Collapse
|
247
|
Abstract
Systemic lupus erythematosus (SLE) is a systemic and poly-aetiological autoimmune disease characterized by the production of antibodies to autologous double-stranded DNA (dsDNA) which serve as diagnostic and prognostic markers. The defective clearance of apoptotic material, together with neutrophil extracellular traps (NETs), provides abundant chromatin or self-dsDNA to trigger the production of anti-dsDNA antibodies, although the mechanisms remain to be elucidated. In SLE patients, the immune complex (IC) of dsDNA and its autoantibodies trigger the robust type I interferon (IFN-I) production through intracellular DNA sensors, which drives the adaptive immune system to break down self-tolerance. In this review, we will discuss the potential resources of self-dsDNA, the mechanisms of self-dsDNA-mediated inflammation through various DNA sensors and its functions in SLE pathogenesis.
Collapse
Affiliation(s)
- Y Bai
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Tong
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Y Liu
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - H Hu
- Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| |
Collapse
|
248
|
Abstract
OBJECTIVE To analyze ankle ligament injury of basketball players caused during movement, summarize injury types, analyze the causes of injury, and put forward corresponding control measures. METHODS The author selected 3100 basketball players with ankle ligament injury during basketball movement and admitted to different hospitals from June 2011 to June 2015 for stochastic analysis. Through the literature, investigation, and observation, etc., common types of injuries of basketball players are analyzed, and damage preventive measures of basketball players are discussed, so as to find measures to prevent and treat ankle ligament injury of basketball players and promote physical rehabilitation of players, which is in favor of their better career development. RESULTS Basketball players are prone to ankle ligament injury in training or competition, which has a direct relationship with players' poor safety consciousness and insufficient preparation during movement. CONCLUSION Basketball players will often have serious ankle ligament injury in the process of movement. Basketball coaches and players should reduce serious injury to players in training or competition, so as to stimulate passion of more professional basketball sports students for basketball, which also has a positive meaning for their future career.
Collapse
Affiliation(s)
- H Hu
- Physical Education Department, Henan Institute of Science and Technology, Xinxiang, China
| |
Collapse
|
249
|
Han GJ, Hu H, Mao D, Bai X, She DY, Zhao SF, Wen ZL, Gao J. [IgG4-related lung disease: analysis of 8 cases and literature review]. Zhonghua Jie He He Hu Xi Za Zhi 2017; 40:193-198. [PMID: 28297814 DOI: 10.3760/cma.j.issn.1001-0939.2017.03.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To improve the understanding and treatment of IgG4-related lung disease (IgG4-RLD). Methods: The clinical characteristics, serum IgG4 levels, pathological features, chest CT, therapy and prognosis of 8 patients with IgG4-RLD were retrospectively analyzed. These patients were admitted to the People's Liberation Army General Hospital and the pathological diagnosis was made between December 2005 and March 2016. Relevant literatures were reviewed. Results: The 8 patients with IgG4-RLD included 4 men and 4 women, with an average age of (59±4) years (range, 37-74). The respiratory symptoms included shortness of breath, cough, and expectoration. Extra-pulmonary symptoms included abdominal pain, facial edema, and fever. Extrapulmonary organs were involved in 7 cases. Serum IgG4 levels were elevated in 8 cases, with an average concentration of(17±6)g/L. Chest CT showed solid lung nodules in 6, alveolar-interstitial infiltration in 5, bronchovascular lesions in 3 and ground glass shadows in 2 cases. PET/CT was performed in 2 cases and it showed multiple organ involvement with higher radioactivity uptake(SUVmax2.9-4.2). The pathological examination found lymphocyte and plasma cell infiltration in 7, fibrous tissue hyperplasia in 5, and occlusive vasculitis in 2 cases. On immunohistochemical staining, the ratio of IgG4-positive plasma cells to IgG-positive plasma cells was higher than 40%in 3 cases. The number of IgG4-positive plasma cells was 10-50/HP in 8 cases. The misdiagnosis rate was 100% before the final diagnosis was made. Three cases received glucocorticoids with immunosuppressant therapy, 2 received surgery combined with glucocorticoid therapy, 2 received glucocorticoid therapy alone, and 1 only received surgery. The follow-up time was 4-132 months, with remission in 7 cases, and disease progression in 1 case, but no death. A total of 195 cases of IgG4-RLD were reviewed from the literature, among whom 111 cases were admitted with respiratory symptoms, 144 with extra-pulmonary involvement. Serum IgG4 levels were detected in 179 cases, with an average concentration of 5.408 g/L. The nodular type was predominant, accounting for 36.9%. Of these cases, 178 received glucocorticoid treatment with disease remission. Conclusions: The major clinical manifestations of IgG4-RLD were shortness of breath, cough and expectoration. Multiple organ lesions were common. The misdiagnosis rate was extremely high. The diagnosis could be made based on pathological features and IgG4 serum levels . Glucocorticoid treatment was effective.
Collapse
Affiliation(s)
- G J Han
- Respiratory Department of People's Liberation Army General Hospital, Beijing 100853, China
| | | | | | | | | | | | | | | |
Collapse
|
250
|
Yang L, Cai Y, Zhang J, Hu H, Wu Z, Deng R, Deng Y. The frequency of RAS mutation in circulating tumor DNA predicts worse survival in patients with mCRC. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx393.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|